ALKS: Revenue rose, but GAAP earnings fell; FY 2026 guidance was reiterated

What happened

Alkermes reported that Q3 revenue and sales of its own products rose compared with a year earlier, while GAAP net income and diluted EPS fell. The company reiterated its full-year 2026 guidance, with Avadel acquisition accounting affecting expenses and LUMRYZ contributing to results.

Confirmed

Global impact / market context

Rising revenue alongside falling GAAP profit means costs grew faster than sales, likely tied to Avadel acquisition accounting. GAAP profit includes accounting charges, so investors should check whether the profit drop reflects real cash costs or one-time items, since that changes how sustainable earnings look.

Analyst inference

Reiterated 2026 guidance signals management expects current trends to continue, reducing near-term forecast uncertainty. Investors will weigh sales growth from LUMRYZ against higher acquisition-related expenses, and decide whether the profit decline is temporary accounting noise or a lasting cost problem.

Analyst inference

What to watch

1. Watch whether future quarters show GAAP net income and diluted EPS recovering as Avadel acquisition accounting effects fade, while revenue and proprietary net sales keep growing. Confirmed
2. Track LUMRYZ sales contribution and expense lines tied to Avadel accounting, since these determine whether higher costs persist or are one-time charges. Confirmed
3. Compare actual results with the reiterated 2026 guidance each quarter, and watch whether management updates that guidance if acquisition costs or LUMRYZ sales differ from expectations. Proposed

Evidence

• Original source link unavailable